Abstract
Summary
A new dye for vitreoretinal surgery comprised of soluble lutein/zeaxanthin 1 % and brilliant blue 0.025 % is advantageous compared with other dyes currently used for chromovitrectomy, and showed no signs of toxicity at 1 month of follow-up.
Purpose
To evaluate the feasibility and safety of a dye [soluble lutein/zeaxanthin (LZ) 1 % and brilliant blue (BB) 0.025 %] for improving removal of vitreous, epiretinal membranes (ERM), and internal limiting membranes (ILM) in humans.
Methods
We prospectively evaluated 18 eyes treated surgically for a macular hole or ERM. Eighteen surgeons performed chromovitrectomy using the dye, and completed a questionnaire to evaluate the efficacy and safety of the dye. . Examinations included best-corrected visual acuity and intraocular pressure measurements and optical coherence tomography, fluorescein angiography, and autofluorescence performed at baseline and days 1, 7, and 30 postoperatively.
Results
The green dye was deposited on the posterior pole; vigorous dye flushing into the vitreous cavity was unnecessary. All surgeons reported that the ILM stained greenish-blue; 94.4 % reported ILM peeling adequate; the ERM stained poorly. No evidence of toxicity was observed.
Conclusion
The new dye deposited on the posterior pole due to its higher density. The ability to stain the ILM was similar to BB. The new dye has ability to stain the vitreous, hyaloid, and especially the ILM satisfactorily. The new dye may be useful during chromovitrectomy.
Similar content being viewed by others
References
Burk SE, Da Mata AP, Snyder ME, Rosa RH Jr, Foster RE (2000) Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology 107(11):2010–2014
Rodrigues EB, Meyer CH, Farah ME, Kroll P (2005) Intravitreal staining of the internal limiting membrane using indocyanine green in the treatment of macular holes. Ophthalmol J Int Ophtalmol Int J Ophthalmol Z Augenheilkd 219(5):251–262
Teba FA, Mohr A, Eckardt C, Wong D, Kusaka S, Joondeph BC et al (2003) Trypan blue staining in vitreoretinal surgery. Ophthalmology 110(12):2409–2412
Kumar A, Prakash G (2004) Differential staining with indocyanine green and trypan blue dye. Indian J Ophthalmol 52(4):339
Perrier M, Sebag M (2003) Epiretinal membrane surgery assisted by trypan blue. Am J Ophthalmol 135(6):909–911
Feron EJ, Veckeneer M, Parys-Van Ginderdeuren R, Van Lommel A, Melles GR, Stalmans P (2002) Trypan blue staining of epiretinal membranes in proliferative vitreoretinopathy. Arch Ophthalmol 120(2):141–144
Peyman GA, Cheema R, Conway MD, Fang T (2000) Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 20(5):554–555
Engelbrecht NE, Freeman J, Sternberg P Jr, Aaberg TM Sr, Aaberg TM Jr, Martin DF et al (2002) Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 133(1):89–94
Yemelyanov AY, Katz NB, Bernstein PS (2001) Ligand-binding characterization of xanthophyll carotenoids to solubilized membrane proteins derived from human retina. Exp Eye Res 72(4):381–392
Ahmed SS, Lott MN, Marcus DM (2005) The macular xanthophylls. Surv Ophthalmol 50(2):183–193
Nolan JSJ, Mellerio J, Godhinio M, Neelam K, Beatty S (2006) Monthly consistency of macular pigment optical density and serum concentrations of lutein and zeaxanthin. Curr Eye Res 31:199–213
Gale CHN, Phillips D, Martyn C (2001) Plasma antioxidant vitamins and carotenoids and age-related cataract. Ophthalmology 108:1992–1998
Snodderly DHG, Adler AJ (1991) Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys. Invest Ophthalmol Vis Sci 32:268–279
Sommerburg OKJ, Bird A, van Kuijk F (1998) Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol 82:907–910
Mares-Perlman JBW, Klein R et al (1995) Serum antioxidants and age-related macular degeneration in a population-based case–control study. Arch Ophthalmol 113:1518–1523
Falsini BPM, Iarossi G, Fadda A, Merendino E, Valentini P (2003) Influence of short-term antioxidant supplementation on macular function in age-related maculopathy. Ophthalmology 110:51–61
Bone RALJ, Mayne ST, Gomez CM, Tibor SE, Twaroska EE (2001) Macular pigment in donor eyes with and without AMD: a case-control study. Invest Ophthalmol Vis Sci 42:235–240
Sousa-Martins D, Maia M, Moraes M, Lima-Filho AA, Rodrigues EB, Chen J et al (2012) Use of lutein and zeaxanthin alone or combined with Brilliant Blue to identify intraocular structures intraoperatively. Retina 32(7):1328–1336
Maia M, Furlani BA, Souza-Lima AA, Martins DS, Navarro RM, Belfort R Jr (2013) LUTEIN: a new dye for chromovitrectomy. Retina.
Farah ME, Maia M, Rodrigues EB (2009) Dyes in ocular surgery: principles for use in chromovitrectomy. Am J Ophthalmol 148(3):332–340
Junghans A, Sies H, Stahl W (2001) Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes. Arch Biochem Biophys 391(2):160–164
Kijlstra A, Tian Y, Kelly ER, Berendschot TT (2012) Lutein: more than just a filter for blue light. Prog Retin Eye Res 31(4):303–315
Maia M, Margalit E, Lakhanpal R, Tso MO, Grebe R, Torres G et al (2004) Effects of intravitreal indocyanine green injection in rabbits. Retina 24(1):69–79
Maia M, Haller JA, Pieramici DJ, Margalit E, De Juan E Jr, Farah ME et al (2004) Retinal pigment epithelial abnormalities after internal limiting membrane peeling guided by indocyanine green staining. Retina 24(1):157–160
Maia M, Kellner L, De Juan E Jr, Smith R, Farah ME, Margalit E et al (2004) Effects of indocyanine green injection on the retinal surface and into the subretinal space in rabbits. Retina 24(1):80–91
Acknowledgments
Many thanks to the study coordinator Luci Silva for the efforts to conclude this study.
Proprietary interest
The use of the combination of lutein/zeaxanthin and brilliant blue in human eyes is protected by international patent law (international patent number 61/468,838). The study was sponsored by Kemin Inc., Des Moines, IA, USA.
Author information
Authors and Affiliations
Corresponding author
Additional information
Clinical trial registration number: NCT01627977
Local ethics committee number: 00553212.8.0000.5505
Rights and permissions
About this article
Cite this article
Badaro, E., Furlani, B., Prazeres, J. et al. Soluble lutein in combination with brilliant blue as a new dye for chromovitrectomy. Graefes Arch Clin Exp Ophthalmol 252, 1071–1078 (2014). https://doi.org/10.1007/s00417-013-2539-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-013-2539-5